ÍÃ×ÓÏÈÉú

Contenu disponible en anglais seulement.

Bulletin de la Bourse

Valeo Pharma Inc. (VPH, VPH.WT) inscrit à la Bourse de Toronto


25 mars 2022

Issuer: Valeo Pharma Inc. (the "Company")

SecuritiesSymbolsTrading CurrencyIssued and Outstanding SecuritiesReserved Securities
Class A shares (the "Shares") VPH CDN$ 81,649,098 70,161,735
Share purchase warrants (the "July 25, 2022 Warrants") VPH.WT CDN$ 7,398,182 0
Share purchase warrants (the "September 10, 2022 Warrants") VPH.WT.A CDN$ 2,875,000 0
Listing category: Industrial, Non-Exempt Issuer
Listing and posted for trading date: March 29, 2022 (at the opening, not subject to a closing)
Other market(s): The Shares have been listed and trading on the Canadian Securities Exchange ("CSE") under the symbol "VPH" since February 20, 2019. The July 25, 2022 Warrants commenced trading on the CSE on July 29, 2019 under the symbol "VPH.WT". The September 10, 2022 Warrants commenced trading on the CSE on September 11, 2020 under the symbol "VPH.WT.A".
 
ÍÃ×ÓÏÈÉú ("TSX") is advised that the Shares, the July 25, 2022 Warrants and the September 10, 2022 Warrants will be delisted from the CSE at the close of market on March 28, 2022.
Temporary market maker: Independent Trading Group (ITG) Inc.
Security ownership registration: Uncertificated Issue – Non-Certificated Inventory & Direct Registration System
Investor relations: Steve Saviuk
Chief Executive Officer
(514) 693-8830
Email: steve.saviuk@valeopharma.com
 
Frédéric Dumais
Director, Communications and Investor Relations
(514) 782-8803
Email: frederic.dumais@valeopharma.com 
Incorporation: Canada Business Corporations Act
Fiscal year end: October 31
Nature of business: The Company is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology, Neurodegenerative Diseases, Oncology and other specialty products.
Transfer agent and registrar: Computershare Investor Services Inc. at its principal office in Montréal and Toronto
Dividends: The Company does not currently intend to declare or pay cash dividends on its Shares in the foreseeable future.
Sponsorship: Desjardins Securities Inc.
Disclosure document: Annual Information Form dated February 28, 2022, which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the disclosure document.

Principal terms of the July 25, 2022 Warrants:

Symbol: VPH.WT
Exercise price: $0.60 per Share
Expiry: 5:00 p.m. (Eastern Standard Time) on July 25, 2022
 
If, at any time prior to the expiry date of the July 25, 2022 Warrants, the volume weighted average trading price of the Shares on TSX equals or exceeds $1.10 for a period of 20 consecutive trading days, the Company may, within 15 days of the occurrence of such event, deliver a notice to the holders of July 25, 2022 Warrants accelerating the expiry date of the July 25, 2022 Warrants to the date that is 30 days following the date of such notice.
Warrant agent: Computershare Trust Company of Canada at its principal office in Montréal
Additional information: Warrant indenture dated July 25, 2019 between the Company and Computershare Trust Company of Canada

Principal terms of the September 10, 2022 Warrants:

Symbol: VPH.WT.A
Exercise price: $1.50 per Share
Expiry: 5:00 p.m. (Montréal time) on September 10, 2022
 
If, at any time prior to the expiry date of the September 10, 2022 Warrants, the closing trading price of the Shares on TSX equals or exceeds $2.00 for a period of ten consecutive trading days, the Company may, following the occurrence of such event, deliver a notice to the holders of September 10, 2022 Warrants accelerating the expiry date of the September 10, 2022 Warrants to the date that is 30 days following the date of such notice.
Warrant Agent: Computershare Trust Company of Canada at its principal office in Montréal
Additional information: Warrant indenture dated September 10, 2020 between the Company and Computershare Trust Company of Canada
TSX contact: Anne Child, Director, TSX Listings